Transmucosal delivery of linagliptin for the treatment of type- 2 diabetes mellitus by ultra-thin nanofibers

Current Drug Delivery

Volumn 12, Issue 3, 2015, Pages 323-332

  Modgill, Vedant ^a   Garg, Tarun ^a   Goyal, Amit K ^a   Rath, Goutam ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Anti diabetic; Controlled release; Linagliptin; Nanofibers; Polyvinyl alcohol

Indexed keywords

HYDROGEN; LINAGLIPTIN; NANOFIBER; POLYVINYL ALCOHOL; ANTIDIABETIC AGENT; DELAYED RELEASE FORMULATION; DIPEPTIDYL PEPTIDASE IV INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CRYSTAL; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; ELECTROSPINNING; EX VIVO STUDY; HYDROGEN BOND; HYDROPHOBICITY; IN VIVO STUDY; MALE; MUCOADHESION; MUCOSAL DRUG ADMINISTRATION; NANOENCAPSULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARTICLE SIZE; PHASE TRANSITION; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SURFACE AREA; SURFACE PROPERTY; WETTABILITY; WISTAR RAT; X RAY DIFFRACTION; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GOAT; MEDICINAL CHEMISTRY; PROCEDURES; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; GOATS; HYPOGLYCEMIC AGENTS; LINAGLIPTIN; MALE; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; POLYVINYL ALCOHOL; RATS; RATS, WISTAR; X-RAY DIFFRACTION;

EID: 84931839966     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811666141117144332     Document Type: Article

References (40)

1. Chaudhary, S.; Garg, T.; Murthy, R. S.; Rath, G.; Goyal, A. K. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J. Drug Target, 2014, 22, 1-12.
2. Kathpalia, H.; Gupte, A. An introduction to fast dissolving oral thin film drug delivery systems: a review. Curr. Drug Deliv., 2013, 10(6), 667-84.
3. Singh, B.; Garg, T.; Goyal, A. K.; Rath, G. Recent advancements in the cardiovascular drug carriers. Artif. Cells Nanomed. Biotechnol., 2014, 1-10.
4. Sharma, A.; Garg, T.; Aman, A.; Panchal, K.; Sharma, R.; Kumar, S.; Markandeywar, T. Nanogel-an advanced drug delivery tool: Current and future. Artif. Cells Nanomed. Biotechnol., 2014, 1-13.
5. Rohilla, R.; Garg, T.; Goyal, A. K.; Rath, G. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv., 2014, 1-17.
6. Pabreja, S.; Garg, T.; Rath, G.; Goyal, A. K. Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes. Artif. Cells Nanomed. Biotechnol., 2014, 1-8.
7. Marwah, H.; Garg, T.; Goyal, A. K.; Rath, G. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv., 2014, 1-15.
8. Kaur, V.; Garg, T.; Rath, G.; Goyal, A. K. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J. Drug Target, 2014, 1-12.
9. Allen, T. M.; Cullis, P. R. Drug delivery systems: entering the mainstream. Science, 2004, 303(5665), 1818-22
10. Bhattacharyya, A.; Bajpai, M. Oral bioavailability and stability study of a selfemulsifying drug delivery system (SEDDS) of amphotericin B. Curr. Drug Deliv., 2013, 10(5), 542-7.
11. Kaur, R.; Garg, T.; Rath, G.; Goyal, A. K. Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit. Rev. Ther. Drug Carrier Syst., 2014, 31(6), 495-530.
12. Gagandeep; Garg, T.; Malik, B.; Rath, G.; Goyal, A. K. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur. J. Pharm. Sci., 2014, 53, 10-6.
13. Garg, T. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif. Cells Nanomed. Biotechnol., 2014, 1-8.
14. Garg, T.; Goyal, A. K. Iontophoresis: Drug Delivery System by Applying an Electrical Potential Across the Skin. Drug Deliv. Lett., 2012, 2(4), 270-280.
15. Garg, T.; Goyal, A. K. Liposomes: Targeted and Controlled Delivery System. Drug Deliv. Lett., 2014, 4(1), 62-71.
16. Garg, T.; Goyal, A. K. Biomaterial-based scaffolds--current status and future directions. Expert Opin. Drug Deliv., 2014, 11(5), 767- 89.
17. Garg, T.; Goyal, A. K. Medicated Chewing Gum: Patient Compliance Oral Drug Delivery System. Drug Deliv. Lett., 2014, 4(1), 72-78.
18. Kaur, R.; Garg, T.; Malik, B.; Gupta, U. D.; Gupta, P.; Rath, G.; Goyal, A. K. Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv., 2014, 1-6.
19. Garg, T.; Goyal, A. K.; Arora, S.; Murthy, R. Development, Optimization & Evaluation of Porous Chitosan Scaffold Formulation of Gliclazide for the Treatment of Type-2 Diabetes Mellitus. Drug Deliv. Lett., 2012, 2(4), 251-261.
20. Kaur, R.; Garg, T.; Das Gupta, U.; Gupta, P.; Rath, G.; Goyal, A. K. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of antitubercular drugs. Artif. Cells Nanomed. Biotechnol., 2014, 1-6.
21. Kaur, P.; Garg, T.; Rath, G.; Murthy, R. S.; Goyal, A. K. Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv., 2014, 1-12.
22. Kaur, N.; Garg, T.; Goyal, A. K.; Rath, G. Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv., 2014, 1-10.
23. Kaur, M.; Malik, B.; Garg, T.; Rath, G.; Goyal, A. K. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv., 2014, 1-12.
24. Kaur, M.; Garg, T.; Rath, G.; Goyal, A. K. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit. Rev. Ther. Drug Carrier Syst., 2014, 31(1), 49-88.
25. Garg, T.; Singh, O.; Arora, S.; Murthy, R. Scaffold: a novel carrier for cell and drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 2012, 29(1), 1-63.
26. Hussain, T.; Garg, T.; Goyal, A.K.; Rath, G. Biomedical Applications of Nanofiber Scaffolds in Tissue Engineering. J. Biomaterials Tissue Eng., 2014, 4(8), 600-623.
27. Sharma, R.; Singh, H.; Joshi, M.; Sharma, A.; Garg, T.; Goyal, A. K.; Rath, G. Recent advances in polymeric electrospun nanofibers for drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 2014, 31(3), 187-217.
28. Singh, H.; Sharma, R.; Joshi, M.; Garg, T.; Goyal, A. K.; Rath, G. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif. Cells Nanomed. Biotechnol., 2014, 1-10.
29. Rajesh, K. P.; Natarajan, T. S. Electrospun polymer nanofibrous membrane for filtration. J. Nanosci. Nanotechnol., 2009, 9(9), 5402-5.
30. Morie, A.; Garg, T.; Goyal, A. K.; Rath, G. Nanofibers as novel drug carrier - An overview. Artif. Cells Nanomed. Biotechnol., 2014, 1-9.
31. Modgill, V.; Garg, T.; Goyal, A. K.; Rath, G. Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif. Cells Nanomed. Biotechnol., 2014, 1-6.
32. Liang, D.; Hsiao, B. S.; Chu, B. Functional electrospun nanofibrous scaffolds for biomedical applications. Adv. Drug Deliv. Rev., 2007, 59(14), 1392-412.
33. Drucker, D. J.; Nauck, M. A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet, 2006, 368(9548), 1696-705.
34. Deacon, C. F. Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for type 2 diabetes. Expert Opin. Investig. Drugs, 2007, 16(4), 533-45.
35. Guedes, E. P.; Hohl, A.; de Melo, T. G.; Lauand, F. Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment. Diabetol. Metab. Syndr., 2013, 5(1), 25.
36. Malik, R.; Garg, T.; Goyal, A. K.; Rath, G. Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J. Drug Target, 2014, 1-16.
37. Ding, J.; He, R.; Zhou, G.; Tang, C.; Yin, C. Multilayered mucoadhesive hydrogel films based on thiolated hyaluronic acid and polyvinylalcohol for insulin delivery. Acta Biomater., 2012, 8(10), 3643-51.
38. Orienti, I.; Bigucci, F.; Gentilomi, G.; Zecchi, V. Self-assembling poly(vinyl alcohol) derivatives, interactions with drugs and control of release. J. Pharm. Sci., 2001, 90(9), 1435-44.
39. An, N. M.; Kim, D. D.; Shin, Y. H.; Lee, C. H. Development of a novel soft hydrogel for the transdermal delivery of testosterone. Drug Dev. Ind. Pharm., 2003, 29(1), 99-105.
40. Sharma, R.; Garg, T.; Goyal, A. K.; Rath, G. Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis. Artif. Cells Nanomed. Biotechnol., 2014, 1-8.